Interestingly, Ginsenoside Rd (GSRd), an ingredient of an herbal medicine with therapeutic effect on ischemic stroke in patients [128], induces early expression of NEIL1 and late expression of NEIL3 in rats, indicating that enhanced BER capacity is fundamental to the maintenance genomic integrity and improved outcomes following ischemic stroke [117]. The gene discussed is NEIL3; the disease is ischemic stroke.